<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38514769</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>25</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2397-3374</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Nature human behaviour</Title><ISOAbbreviation>Nat Hum Behav</ISOAbbreviation></Journal><ArticleTitle>Long-term risk of psychiatric disorder and psychotropic prescription after SARS-CoV-2 infection among UK general population.</ArticleTitle><Pagination><StartPage>1076</StartPage><EndPage>1087</EndPage><MedlinePgn>1076-1087</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41562-024-01853-4</ELocationID><Abstract><AbstractText>Despite evidence indicating increased risk of psychiatric issues among COVID-19 survivors, questions persist about long-term mental health outcomes and the protective effect of vaccination. Using UK Biobank data, three cohorts were constructed: SARS-CoV-2 infection (n&#x2009;=&#x2009;26,101), contemporary control with no evidence of infection (n&#x2009;=&#x2009;380,337) and historical control predating the pandemic (n&#x2009;=&#x2009;390,621). Compared with contemporary controls, infected participants had higher subsequent risks of incident mental health at 1&#x2009;year (hazard ratio (HR): 1.54, 95% CI 1.42-1.67; P&#x2009;=&#x2009;1.70&#x2009;&#xd7;&#x2009;10<sup>-24</sup>; difference in incidence rate: 27.36, 95% CI 21.16-34.10 per 1,000 person-years), including psychotic, mood, anxiety, alcohol use and sleep disorders, and prescriptions for antipsychotics, antidepressants, benzodiazepines, mood stabilizers and opioids. Risks were higher for hospitalized individuals (2.17, 1.70-2.78; P&#x2009;=&#x2009;5.80&#x2009;&#xd7;&#x2009;10<sup>-10</sup>) than those not hospitalized (1.41, 1.30-1.53; P&#x2009;=&#x2009;1.46&#x2009;&#xd7;&#x2009;10<sup>-16</sup>), and were reduced in fully vaccinated people (0.97, 0.80-1.19; P&#x2009;=&#x2009;0.799) compared with non-vaccinated or partially vaccinated individuals (1.64, 1.49-1.79; P&#x2009;=&#x2009;4.95&#x2009;&#xd7;&#x2009;10<sup>-26</sup>). Breakthrough infections showed similar risk of psychiatric diagnosis (0.91, 0.78-1.07; P&#x2009;=&#x2009;0.278) but increased prescription risk (1.42, 1.00-2.02; P&#x2009;=&#x2009;0.053) compared with uninfected controls. Early identification and treatment of psychiatric disorders in COVID-19 survivors, especially those severely affected or unvaccinated, should be a priority in the management of long COVID. With the accumulation of breakthrough infections in the post-pandemic era, the findings highlight the need for continued optimization of strategies to foster resilience and prevent escalation of subclinical mental health symptoms to severe disorders.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Yunhe</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0923-1441</Identifier><AffiliationInfo><Affiliation>Nuffield Department of Population Health, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Su</LastName><ForeName>Binbin</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-1814-024X</Identifier><AffiliationInfo><Affiliation>School of Population Medicine and Public Health, Chinese Academy of Medical Sciences/Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Junqing</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0040-0042</Identifier><AffiliationInfo><Affiliation>Centre for Statistics in Medicine and NIHR Biomedical Research Centre Oxford, NDORMS, University of Oxford, Oxford, UK. Junqing.xie@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, China. Junqing.xie@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, China. Junqing.xie@ndorms.ox.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Rizo</LastName><ForeName>Clemente</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Barcelona Clinic Schizophrenia Unit, Hospital Cl&#xed;nic de Barcelona, Departament de Medicina, Institut de Neuroci&#xe8;ncies (UBNeuro), Universitat de Barcelona (UB), Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERSAM, ISCIII, Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institut d'Investigacions Biom&#xe8;diques August Pi I Sunyer (IDIBAPS), Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prieto-Alhambra</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centre for Statistics in Medicine and NIHR Biomedical Research Centre Oxford, NDORMS, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Informatics, Erasmus Medical Center University, Rotterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Hum Behav</MedlineTA><NlmUniqueID>101697750</NlmUniqueID><ISSNLinking>2397-3374</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011619">Psychotropic Drugs</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001523" MajorTopicYN="Y">Mental Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011619" MajorTopicYN="Y">Psychotropic Drugs</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011307" MajorTopicYN="N">Drug Prescriptions</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>C.G.-R. has received honoraria/travel support from Abbot, Angelini, Cassen-Recordati, Janssen-Cilag, and Lundbeck. D.P.-A. reported grants from Amgen, UCB Biopharma, Les Laboratoires Servier, Novartis, and Chiesi-Taylor, as well as speaker fees and advisory board membership with AstraZeneca and Johnson and Johnson outside the submitted work, in addition to research support from Janssen. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>26</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>22</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38514769</ArticleId><ArticleId IdType="pmc">PMC11199144</ArticleId><ArticleId IdType="doi">10.1038/s41562-024-01853-4</ArticleId><ArticleId IdType="pii">10.1038/s41562-024-01853-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO COVID-19 Dashboard (World Health Organization, 2024).</Citation></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2013;mechanisms, risk factors, and management. Br. Med. J. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. Br. Med. J. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift AK, et al. Neuropsychiatric ramifications of severe COVID-19 and other severe acute respiratory infections. JAMA Psychiatry. 2022;79:690&#x2013;698. doi: 10.1001/jamapsychiatry.2022.1067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.1067</ArticleId><ArticleId IdType="pmc">PMC9096686</ArticleId><ArticleId IdType="pubmed">35544272</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Geddes JR, Husain M, Luciano S, Harrison PJ. 6-month neurological and psychiatric outcomes in 236379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140. doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Al-Aly Z. Risks of mental health outcomes in people with covid-19: cohort study. Br. Med. J. 2022;376:e068993. doi: 10.1136/bmj-2021-068993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068993</ArticleId><ArticleId IdType="pmc">PMC8847881</ArticleId><ArticleId IdType="pubmed">35172971</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu E, Xie Y, Al-Aly Z. Long-term neurologic outcomes of COVID-19. Nat. Med. 2022;28:2406&#x2013;2415. doi: 10.1038/s41591-022-02001-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02001-z</ArticleId><ArticleId IdType="pmc">PMC9671811</ArticleId><ArticleId IdType="pubmed">36138154</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Harrison PJ. Six-month sequelae of post-vaccination SARS-CoV-2 infection: a retrospective cohort study of 10,024 breakthrough infections. Brain Behav. Immun. 2022;103:154&#x2013;162. doi: 10.1016/j.bbi.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2022.04.013</ArticleId><ArticleId IdType="pmc">PMC9013695</ArticleId><ArticleId IdType="pubmed">35447302</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, et al. Trajectory of long covid symptoms after covid-19 vaccination: community based cohort study. Br. Med. J. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund LC, et al. Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study. Lancet Infect. Dis. 2021;21:1373&#x2013;1382. doi: 10.1016/S1473-3099(21)00211-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00211-5</ArticleId><ArticleId IdType="pmc">PMC8110209</ArticleId><ArticleId IdType="pubmed">33984263</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel KM, et al. Association of SARS-CoV-2 infection with psychological distress, psychotropic prescribing, fatigue, and sleep problems among UK primary care patients. JAMA Netw. Open. 2021;4:e2134803. doi: 10.1001/jamanetworkopen.2021.34803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.34803</ArticleId><ArticleId IdType="pmc">PMC8596199</ArticleId><ArticleId IdType="pubmed">34783824</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, et al. Long covid outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study. Br. Med. J. 2023;380:e072529. doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai J, et al. Factors associated with mental health outcomes among health care workers exposed to coronavirus disease 2019. JAMA Netw. Open. 2020;3:e203976. doi: 10.1001/jamanetworkopen.2020.3976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.3976</ArticleId><ArticleId IdType="pmc">PMC7090843</ArticleId><ArticleId IdType="pubmed">32202646</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, et al. The impact of quarantine on mental health status among general population in China during the COVID-19 pandemic. Mol. Psychiatry. 2021;26:4813&#x2013;4822. doi: 10.1038/s41380-021-01019-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01019-y</ArticleId><ArticleId IdType="pmc">PMC7821451</ArticleId><ArticleId IdType="pubmed">33483692</ArticleId></ArticleIdList></Reference><Reference><Citation>Penninx BW, Benros ME, Klein RS, Vinkers CH. How COVID-19 shaped mental health: from infection to pandemic effects. Nat. Med. 2022;28:2027&#x2013;2037. doi: 10.1038/s41591-022-02028-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02028-2</ArticleId><ArticleId IdType="pmc">PMC9711928</ArticleId><ArticleId IdType="pubmed">36192553</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks SK, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912&#x2013;920. doi: 10.1016/S0140-6736(20)30460-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30460-8</ArticleId><ArticleId IdType="pmc">PMC7158942</ArticleId><ArticleId IdType="pubmed">32112714</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595:565&#x2013;571. doi: 10.1038/s41586-021-03710-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav. Immun. 2020;87:34&#x2013;39. doi: 10.1016/j.bbi.2020.04.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Batty GD, Gale CR, Kivim&#xe4;ki M, Deary IJ, Bell S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. Br. Med. J. 2020;368:m131. doi: 10.1136/bmj.m131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m131</ArticleId><ArticleId IdType="pmc">PMC7190071</ArticleId><ArticleId IdType="pubmed">32051121</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemi MEK, et al. Mapping the human genetic architecture of COVID-19. Nature. 2021;600:472&#x2013;477. doi: 10.1038/s41586-021-03767-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03767-x</ArticleId><ArticleId IdType="pmc">PMC8674144</ArticleId><ArticleId IdType="pubmed">34237774</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1&#x2009;284&#x2009;437 patients. Lancet Psychiatry. 2022;9:P815&#x2013;827. doi: 10.1016/S2215-0366(22)00260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(22)00260-7</ArticleId><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Bycroft C, et al. The UK Biobank resource with deep phenotyping and genomic data. Nature. 2018;562:203&#x2013;209. doi: 10.1038/s41586-018-0579-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0579-z</ArticleId><ArticleId IdType="pmc">PMC6786975</ArticleId><ArticleId IdType="pubmed">30305743</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370:1453&#x2013;1457. doi: 10.1016/S0140-6736(07)61602-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong, J. et al. Dynamic linkage of COVID-19 test results between Public Health England&#x2019;s Second Generation Surveillance System and UK Biobank. Microb. Genom.10.1099/mgen.0.000397 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7478634</ArticleId><ArticleId IdType="pubmed">32553051</ArticleId></ArticleIdList></Reference><Reference><Citation>English Indices of Deprivation (GOV.UK, updated 13 December 2012); https://www.gov.uk/government/collections/english-indices-of-deprivation</Citation></Reference><Reference><Citation>Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987;40:373&#x2013;383. doi: 10.1016/0021-9681(87)90171-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0021-9681(87)90171-8</ArticleId><ArticleId IdType="pubmed">3558716</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P, et al. Mapping ICD-10 and ICD-10-CM codes to Phecodes: workflow development and initial evaluation. JMIR Med. Inf. 2019;7:e14325. doi: 10.2196/14325.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/14325</ArticleId><ArticleId IdType="pmc">PMC6911227</ArticleId><ArticleId IdType="pubmed">31553307</ArticleId></ArticleIdList></Reference><Reference><Citation>VanderWeele TJ. Principles of confounder selection. Eur. J. Epidemiol. 2019;34:211&#x2013;219. doi: 10.1007/s10654-019-00494-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-019-00494-6</ArticleId><ArticleId IdType="pmc">PMC6447501</ArticleId><ArticleId IdType="pubmed">30840181</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneeweiss S. Automated data-adaptive analytics for electronic healthcare data to study causal treatment effects. Clin. Epidemiol. 2018;10:771&#x2013;788. doi: 10.2147/CLEP.S166545.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S166545</ArticleId><ArticleId IdType="pmc">PMC6039060</ArticleId><ArticleId IdType="pubmed">30013400</ArticleId></ArticleIdList></Reference><Reference><Citation>Moynihan R, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11:e045343. doi: 10.1136/bmjopen-2020-045343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-045343</ArticleId><ArticleId IdType="pmc">PMC7969768</ArticleId><ArticleId IdType="pubmed">33727273</ArticleId></ArticleIdList></Reference><Reference><Citation>Haukoos JS, Lewis RJ. The propensity score. JAMA. 2015;314:1637&#x2013;1638. doi: 10.1001/jama.2015.13480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.13480</ArticleId><ArticleId IdType="pmc">PMC4866501</ArticleId><ArticleId IdType="pubmed">26501539</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, J. &amp; Kirk-Wade, E. Coronavirus: A History of English Lockdown Laws House of Commons Library Briefing Paper (UK Parliament, 2021).</Citation></Reference><Reference><Citation>Lipsitch M, Tchetgen ET, Cohen T. Negative controls: a tool for detecting confounding and bias in observational studies. Epidemiology. 2010;21:383&#x2013;388. doi: 10.1097/EDE.0b013e3181d61eeb.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181d61eeb</ArticleId><ArticleId IdType="pmc">PMC3053408</ArticleId><ArticleId IdType="pubmed">20335814</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>